XWAR
ONO
Market cap10mUSD
Jul 09, Last price
0.60PLN
1D
0.00%
1Q
3.08%
Jan 2017
-46.25%
Name
Onesano SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1995 and based in Chorzów, Poland, onesano S.A. specializes in research and development within Poland, particularly in dietetics, animal nutrition, bioremediation, and agrotechnological processes. The company provides a range of human dietary supplements, notably under its Estrovita brand. Additionally, it offers animal health products such as Yarrowia Equinox, Yarrowia Canifelox, and Yarrowia Farminox. Its broader product portfolio encompasses various dietary supplements, food additives, functional foods, and raw materials for cosmetic use. onesano distributes its offerings through a comprehensive network including chain pharmacies, pharmaceutical wholesalers, organic/health food stores, drugstores, e-commerce platforms, zoological outlets, veterinary clinics, zoological and veterinary wholesalers, as well as directly to producers of animal feed and supplementary mixtures and contract manufacturers. The company, previously known as Skotan SA, officially adopted the name onesano S.A. in March 2023.
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||